Mechanisms of daptomycin resistance inStaphylococcus aureus: role of the cell membrane and cell wall
出版年份 2012 全文链接
标题
Mechanisms of daptomycin resistance inStaphylococcus aureus: role of the cell membrane and cell wall
作者
关键词
-
出版物
Annals of the New York Academy of Sciences
Volume 1277, Issue 1, Pages 139-158
出版商
Wiley
发表日期
2012-12-06
DOI
10.1111/j.1749-6632.2012.06819.x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Telavancin in Therapy of Experimental Aortic Valve Endocarditis in Rabbits Due to Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus
- (2012) Yan Q. Xiong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies
- (2012) Yang Song et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response
- (2012) Vanina Dengler et al. FEMS MICROBIOLOGY LETTERS
- Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic Patients
- (2012) N. N. Mishra et al. JOURNAL OF INFECTIOUS DISEASES
- Attachment of Capsular Polysaccharide to the Cell Wall in Streptococcus pneumoniae
- (2012) Alice Eberhardt et al. Microbial Drug Resistance
- Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus
- (2012) Anton Y. Peleg et al. PLoS One
- Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome
- (2012) Kirandeep Bhullar et al. PLoS One
- Evaluation of Telavancin Activity versus Daptomycin and Vancomycin against Daptomycin-Nonsusceptible Staphylococcus aureus in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Molly E. Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adjunctive Rifampin Is Crucial to Optimizing Daptomycin Efficacy against Rabbit Prosthetic Joint Infection Due to Methicillin-Resistant Staphylococcus aureus
- (2011) Azzam Saleh-Mghir et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical Methicillin-Resistant Staphylococcus aureus Isolates Obtained before and after Daptomycin Treatment Failure
- (2011) Susan Boyle-Vavra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2011) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftaroline Activity versus Daptomycin (DAP) against DAP-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strains in anIn VitroPharmacokinetic/Pharmacodynamic Model
- (2011) Molly Steed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduction in Membrane Phosphatidylglycerol Content Leads to Daptomycin Resistance in Bacillus subtilis
- (2011) Anna-Barbara Hachmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlation of Daptomycin Resistance in a ClinicalStaphylococcus aureusStrain with Increased Cell Wall Teichoic Acid Production and d-Alanylation
- (2011) Ute Bertsche et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oligomerization of daptomycin on membranes
- (2011) Jawad K. Muraih et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Characterization of daptomycin oligomerization with perylene excimer fluorescence: Stoichiometric binding of phosphatidylglycerol triggers oligomer formation
- (2011) Jawad K. Muraih et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- In vitro time–kill analysis of oritavancin against clinical isolates of methicillin-resistant Staphylococcus aureus with reduced susceptibility to daptomycin
- (2011) Céline Vidaillac et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A widespread family of bacterial cell wall assembly proteins
- (2011) Yoshikazu Kawai et al. EMBO JOURNAL
- A Very Early-Branching Staphylococcus aureus Lineage Lacking the Carotenoid Pigment Staphyloxanthin
- (2011) Deborah C. Holt et al. Genome Biology and Evolution
- Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia
- (2011) Eun Young Choi et al. INTENSIVE CARE MEDICINE
- Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus
- (2011) Diixa Patel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure
- (2011) J. Joson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach
- (2011) Adrien Fischer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multiple Peptide Resistance Factor (MprF)-mediated Resistance ofStaphylococcus aureusagainst Antimicrobial Peptides Coincides with a Modulated Peptide Interaction with Artificial Membranes Comprising Lysyl-Phosphatidylglycerol
- (2011) Jörg Andrä et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids
- (2011) Christoph M. Ernst et al. MOLECULAR MICROBIOLOGY
- Peptidoglycan Crosslinking Relaxation Plays an Important Role in Staphylococcus aureus WalKR-Dependent Cell Viability
- (2011) Aurelia Delaune et al. PLoS One
- Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?
- (2011) Steven Y. C. Tong et al. Seminars in Immunopathology
- Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
- (2011) Benjamin P. Howden et al. PLoS Pathogens
- Successful Treatment of Vancomycin-Intermediate Staphylococcus aureus Pacemaker Lead Infective Endocarditis with Telavancin
- (2010) L. A. Marcos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Regulation ofmprFby Antisense RNA Restores Daptomycin Susceptibility to Daptomycin-Resistant Isolates ofStaphylococcus aureus
- (2010) Aileen Rubio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lysyl-Phosphatidylglycerol Attenuates Membrane Perturbation Rather than Surface Association of the Cationic Antimicrobial Peptide 6W-RP-1 in a Model Membrane System: Implications for Daptomycin Resistance
- (2010) E. Kilelee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carotenoid-Related Alteration of Cell Membrane Fluidity ImpactsStaphylococcus aureusSusceptibility to Host Defense Peptides
- (2010) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms
- (2010) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method
- (2010) Jiun-Ling Wang et al. BMC INFECTIOUS DISEASES
- Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia
- (2010) Nadia Z. Haque et al. CHEST
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection
- (2010) O. Cirioni et al. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II
- (2010) Erik de Leeuw et al. FEBS LETTERS
- Human -Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci
- (2010) V. Sass et al. INFECTION AND IMMUNITY
- Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis
- (2010) M. Lefebvre et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin
- (2010) Y. K. Yoon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- cwrA, a gene that specifically responds to cell wall damage in Staphylococcus aureus
- (2010) C. J. Balibar et al. MICROBIOLOGY-SGM
- Changing the phospholipid composition ofStaphylococcus aureuscauses distinct changes in membrane proteome and membrane-sensory regulators
- (2010) Susanne Sievers et al. PROTEOMICS
- The Lipopeptide Antibiotic Friulimicin B Inhibits Cell Wall Biosynthesis through Complex Formation with Bactoprenol Phosphate
- (2009) T. Schneider et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis
- (2009) H. F. Chambers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin versus Friulimicin B: In-Depth Profiling of Bacillus subtilis Cell Envelope Stress Responses
- (2009) T. Wecke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II
- (2009) C. S. Lunde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains
- (2009) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Analysis of Factors Affecting Susceptibility of Bacillus subtilis to Daptomycin
- (2009) A.-B. Hachmann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus
- (2009) N. N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin: mechanisms of action and resistance, and biosynthetic engineering
- (2009) Richard H Baltz CURRENT OPINION IN CHEMICAL BIOLOGY
- Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE)
- (2009) B. A. Cunha et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies
- (2009) J. N. Steenbergen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
- (2009) A. C. Musta et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureus
- (2009) Soo‐Jin Yang et al. JOURNAL OF INFECTIOUS DISEASES
- Waves of resistance: Staphylococcus aureus in the antibiotic era
- (2009) Henry F. Chambers et al. NATURE REVIEWS MICROBIOLOGY
- The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
- (2009) Christoph M. Ernst et al. PLoS Pathogens
- Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2008) W. E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria
- (2008) K. M. Krause et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus
- (2008) N. Cotroneo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005
- (2008) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia
- (2008) M. Sharma et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Mode of action of human β-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge
- (2008) Vera Sass et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- The Mevalonate Pathway ofStaphylococcus aureus
- (2008) Carl J. Balibar et al. JOURNAL OF BACTERIOLOGY
- The Virulence Regulator Sae of Staphylococcus aureus: Promoter Activities and Response to Phagocytosis-Related Signals
- (2008) T. Geiger et al. JOURNAL OF BACTERIOLOGY
- Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate
- (2008) M. H. Murthy et al. JOURNAL OF MEDICAL MICROBIOLOGY
- A sensor histidine kinase co-ordinates cell wall architecture with cell division inBacillus subtilis
- (2008) Tatsuya Fukushima et al. MOLECULAR MICROBIOLOGY
- A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway
- (2008) Sarah Dubrac et al. MOLECULAR MICROBIOLOGY
- A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence
- (2008) C.-I Liu et al. SCIENCE
- Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2007) A. Soriano et al. CLINICAL INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started